Vertex Pharmaceuticals Incorporated VRTX
Set alert
553.15 USD -5.73 -1.03%
At close · Nov 2
556.00 +2.85 +0.52%
After hours · Nov 2, 7:47 PM ET
544.09 Day range 568.67
403.16 52-week range 568.67
- YTD
- +22.01%
- 1 year
- +29.98%
- Open
- 560.88
- Prev close
- 558.88
- Mkt cap
- 140.11B
- Vol
- 3.21M
- Avg vol
- 1.20M
- EPS
- 17.17
- P/E
- 32.22
- Div yield
- 0.00%
More statistics
- Low
- 544.09
- High
- 568.67
- Forward P/E
- 27.09
- Beta
- 0.28
- Short ratio
- 3.66
- Inst. own
- 98.10%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 2, 2026
- 50-d avg
- 523.21
- 200-d avg
- 479.21
- 1y target
- 571.46
MAX chart
Events in this range
- Aug 4, 2025Earnings: 4.52; estimate 4.29; surprise 5.36%
- Nov 3, 2025Earnings: 4.8; estimate 4.57; surprise 5.03%
- May 4, 2026Earnings: 4.47; estimate 4.24; surprise 5.42%
- Aug 3, 2026Earnings: 4.73; estimate 4.74; surprise -0.21%
- Aug 4, 2026Rating: Cantor Fitzgerald · Overweight → Overweight
- Aug 4, 2026Rating: TD Cowen · Buy → Buy
- Aug 5, 2026Rating: Barclays · Overweight → Overweight
- Aug 5, 2026Rating: Truist Securities · Buy → Buy
- Nov 2, 2026Earnings: —; estimate 4.82; surprise —%
Signals (166)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Aug 1, 2026 | 3 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 1, 2026 | 6 months ago |
| SMA: Bearish | Apr 1, 2026 | 7 months ago |
| SMA: Bearish | Apr 1, 2026 | 7 months ago |
| SMA: Bullish | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Oct 1, 2025 | 1 year ago |
| SMA: Bearish | Aug 1, 2025 | 1 year ago |
| SMA: Bearish | May 1, 2025 | 1 year ago |
| SMA: Bullish | Jan 1, 2025 | 1 year ago |
| SMA: Bearish | Dec 1, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 1, 2024 | 1 year ago |
| RSI: Overbought | May 1, 2024 | 2 years ago |
| RSI: Overbought | Dec 1, 2023 | 2 years ago |
| SMA: Bullish | Mar 1, 2023 | 3 years ago |
| SMA: Bearish | Feb 1, 2023 | 3 years ago |
| RSI: Overbought | Oct 1, 2022 | 4 years ago |
| MACD: Buy Signal | Mar 1, 2022 | 4 years ago |
| SMA: Bullish | Jan 1, 2022 | 4 years ago |
| SMA: Bullish | Dec 1, 2021 | 4 years ago |
Newest 20 of 166.
Peers
Companies in the same industry
| Symbol | Name | Last | Change | Change % | YTD | Market cap |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 170.33 | -0.35 | -0.21% | +38.77% | 211.27B |
| ABBV | AbbVie Inc. | 288.84 | -6.05 | -2.05% | +26.41% | 510.41B |
| MRK | Merck & Co., Inc. | 148.36 | -1.16 | -0.78% | +40.95% | 366.03B |
| BMY | Bristol-Myers Squibb Company | 63.02 | +0.54 | +0.86% | +16.83% | 128.82B |
| JNJ | Johnson & Johnson | 270.56 | -2.64 | -0.97% | +30.74% | 651.32B |
| ENZN | Viskase Companies, Inc. | 4.71 | 0.00 | 0.00% | +11,675.00% | 31.14M |
| ENTA | Enanta Pharmaceuticals, Inc. | 10.43 | -0.28 | -2.61% | -33.86% | 303.78M |